Wen-Xiong Xu (Wexiong Xu, Wenxiong Xu)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 10

Top Venues

Canadian journal of gastroenterology & hepatology

Bioscience, biotechnology, and biochemistry

Current oncology (Toronto, Ont.)

Stem cells international

Third Affiliated Hospital of Sun Yat-Sen University

Sun Yat-Sen University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Third Affiliated Hospital of Sun Yat-Sen University Jan 01 2014

China

Attending physician :: Department of Infectious Diseases

Third Affiliated Hospital of Sun Yat-Sen University Jul 06 2009 - Dec 31 2013

China

Resident :: Department of Infectious Diseases

Education History

Sun Yat-Sen University - Jun 20 2018

China

PHD

Publications

Wen-Xiong Xu, Yan-Lin Huang, Yong-Yu Mei, Yeqiong Zhang, Qiumin Luo, Shu Zhu, Liang Peng, Zhiliang Gao, Ying Liu, Jian-Guo Li
High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma. Current oncology (Toronto, Ont.) 29 (11) (2022)
Wen-Xiong Xu, Yangmei Li, Lu Wang, Hongbo Gao, Jinjun Chen, Jing Yuan, Yi Ouyang, Yufeng Gao, Jianguo Li, Xuejun Li, Liang Peng
Efficacy and safety of combination treatment of double plasma molecular adsorption system and low volume plasma exchange for patients with hepatitis B virus related acute-on-chronic liver failure: a multicentre randomised controlled clinical trial. BMJ open 11 (12) (2021)
Yong-Yu Mei, You-Ming Chen, Yuan-Kai Wu, Xiao-Hong Zhang, Wen-Xiong Xu
Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection. Canadian journal of gastroenterology & hepatology 2020 (2020)
Xiuhua Jia, Zhishuo Mo, Qiyi Zhao, Tiancheng Bao, Wen-Xiong Xu, Zhiliang Gao, Liang Peng, Xiang Zhu
Transcriptome alterations in HepG2 cells induced by shRNA knockdown and overexpression of TMEM2 gene. Bioscience, biotechnology, and biochemistry 84 (8) (2020)
Gang Ning, Li-Min Zhen, Wen-Xiong Xu, Xue-Jun Li, Li-Na Wu, Ying Liu, Chan Xie, Liang Peng
Suppression of complement component 2 expression by hepatitis B virus contributes to the viral persistence in chronic hepatitis B patients. Journal of viral hepatitis 27 (10) (2020)
Gang Ning, Yan-Lin Huang, Li-Min Zhen, Wen-Xiong Xu, Xue-Jun Li, Li-Na Wu, Ying Liu, Chan Xie, Liang Peng
Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma. BioMed research international 2020 (2020)
Kuai Yu, Jingjing He, Yongjian Wu, Baosong Xie, Xuefei Liu, Bo Wei, Haibo Zhou, Bingliang Lin, Zhi-Xiang Zuo, Wen Wen, Wen-Xiong Xu, Bin Zou, Lai Wei, Xi Huang, Penghui Zhou
Dysregulated adaptive immune response contributes to severe COVID-19. Cell research 30 (9) (2020)
Wen-Xiong Xu, Liang Peng
Response to: Comment on "48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse". Canadian journal of gastroenterology & hepatology 2019 (2019)
Wen-Xiong Xu, Hong-Liang He, Shun-Wen Pan, Yuan-Li Chen, Mei-Ling Zhang, Shu Zhu, Zhi-Liang Gao, Liang Peng, Jian-Guo Li
Combination Treatments of Plasma Exchange and Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation for Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure: A Clinical Trial in China. Stem cells international 2019 (2019)
Wen-Xiong Xu, Qian Zhang, Xiang Zhu, Chao-Shuang Lin, You-Ming Chen, Hong Deng, Yong-Yu Mei, Zhi-Xin Zhao, Dong-Ying Xie, Zhi-Liang Gao, Chan Xie, Liang Peng
48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse. Canadian journal of gastroenterology & hepatology 2018 (2018)

Wen-Xiong Xu.css-eqlu8i{font-size:small;padding-left:4px;} (Wexiong Xu, Wenxiong Xu)

Publication Activity (10 Years)

Top Topics

Top Venues

Wen-Xiong Xu (Wexiong Xu, Wenxiong Xu)